News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Novartis Pharma Receives Approval For Zometa Injection
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Novartis Pharma has announced that it received approval for Zometa Injection 4mg, an agent used in the treatment of hypercalcemia of malignancy, from the Ministry of Health, Labor and Welfare on October 22.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Asia
MORE ON THIS TOPIC
Gene editing
FDA bolsters bespoke therapy framework with new draft safety guidelines
April 14, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Lilly investing billions to prepare for overseas oral GLP-1 launches
April 14, 2026
·
2 min read
·
Nick Paul Taylor
Antibody-drug conjugate (ADC)
BioNTech, DualityBio tout ‘clinically meaningful’ efficacy for ADC in mid-stage endometrial cancer trial
April 13, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
April 13, 2026
·
2 min read
·
Nick Paul Taylor
